Treatment of severe toxemia of pregnancy with intravenous magnesium sulfate and apresoline.
D061605:Administration, Intravenous; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000628:therapy*; D011247:Pregnancy
D006830:Hydralazine; D008278:Magnesium Sulfate
HYDRALAZINE/therapeutic use; MAGNESIUM SULFATE/therapeutic use; PREGNANCY TOXEMIAS/therapy